Organigram Global (TSX:OGI) Debt-to-Equity : 0.03 (As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Organigram Global Debt-to-Equity?

Organigram Global's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was C$1.5 Mil. Organigram Global's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was C$8.5 Mil. Organigram Global's Total Stockholders Equity for the quarter that ended in Dec. 2024 was C$323.6 Mil. Organigram Global's debt to equity for the quarter that ended in Dec. 2024 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Organigram Global's Debt-to-Equity or its related term are showing as below:

TSX:OGI' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.01 Med: 0.15 Max: 0.69
Current: 0.03

During the past 12 years, the highest Debt-to-Equity Ratio of Organigram Global was 0.69. The lowest was -0.01. And the median was 0.15.

TSX:OGI's Debt-to-Equity is ranked better than
88.45% of 814 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs TSX:OGI: 0.03

Organigram Global Debt-to-Equity Historical Data

The historical data trend for Organigram Global's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organigram Global Debt-to-Equity Chart

Organigram Global Annual Data

Trend

Apr14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Sep24

Debt-to-Equity

Get a 7-Day Free Trial

0.15

0.39

0.01

0.02

Organigram Global Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	0.02	0.03

Competitive Comparison of Organigram Global's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organigram Global's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Organigram Global's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Organigram Global Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Organigram Global's Debt to Equity Ratio for the fiscal year that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.086	+	3.369)	/	305.989
	=	0.01

Organigram Global's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.454	+	8.484)	/	323.647
	=	0.03

Organigram Global (TSX:OGI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Organigram Global Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Organigram Global's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Organigram Global Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organigram Global Inc (TSX:OGI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

OGI:USA 0OG:Germany

Address

145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8

Website

https://www.organigram.ca

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Executives

Beena Goldenberg	Senior Officer
Dexter John	Director
Sherry Porter	Director
Stephen A. Smith	Director
Gregory Guyatt	Senior Officer
Paolo De Luca	Senior Officer
Katrina May Mcfadden	Senior Officer
Donald Geoffrey Machum	Director
Derrick West	Senior Officer
Michel Bourque	Director
Kenneth Arnold Mitton	Director
Denis Joseph Robert Arsenault	10% Security Holder, Director, Senior Officer